Company profile: Nanomi
1.1 - Company Overview
Company description
- Provider of microsphere and nanoparticle manufacturing and long-acting release medicine development, leveraging proprietary Microsieve technology for uniform particle size and precise extended dosing, and Monosphere technology for biodegradable monodisperse particles that encapsulate active compounds for controlled, long-term release; develops products in-house and in collaboration.
Products and services
- Microsphere and nanoparticle engineering and development: Long-acting release service that engineers and produces microspheres and nanoparticles, with a pipeline using proprietary Microsieve technology, developed in-house and through collaborations
- Microsieve Technology: Proprietary system for developing long-acting release medicines with uniform particle size and shape, delivering precise dosing over extended periods and underpinning a pipeline developed in-house and through collaborations
- Nanomi Monosphere Technology: Biodegradable method that creates monodisperse particles encapsulating active pharmaceutical compounds for controlled, long-term release.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nanomi
Magnolia Solar
HQ: United States
Website
- Description: Provider of thin-film solar cell technology and modules employing nanostructured materials and designs, focused on developing and commercializing low-cost, high-efficiency solutions to advance green technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Magnolia Solar company profile →
Vironova
HQ: Sweden
Website
- Description: Provider of solutions for sub-visible particle analysis, offering products and services used in the development of particles for vaccines, drug delivery and gene therapy, as well as viral safety testing and material quality control; founded in 2005 from interdisciplinary research at the Karolinska Institute in Stockholm, Sweden.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vironova company profile →
LESS
HQ: Switzerland
Website
- Description: Provider of nano-active fiber lighting technology and ultra-thin, bright, uniform technical lighting systems in small form factors. Offers automotive lighting for three-dimensional signal lights and inspection lamps for pharmaceutical, watchmaking, and electronics industries, delivering powerful, uniform, stable, directional or diffuse light to detect particles and imperfections for quality control.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LESS company profile →
InnoMedica
HQ: Switzerland
Website
- Description: Provider of patented liposomal nanocarrier drug delivery technology enabling selective, localized transport of active agents to affected areas, improving efficacy and reducing side effects. Offers oncology TLD-1 (Doxorubicin to tumors) and neurology TLN-1 (GM1-Ganglioside across the blood-brain barrier), GMP in-house manufacturing, and a pipeline of liposomal formulations for established and new substances, including RNA or proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InnoMedica company profile →
Cresilon
HQ: United States
Website
- Description: Provider of plant-based hemostatic gel solutions for trauma care, offering VETIGEL for veterinary use and Cresilon Hemostatic Gel (CHG) for human use. VETIGEL is biocompatible and stops bleeding in seconds; both gels work quickly without the need for manual pressure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cresilon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nanomi
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nanomi
2.2 - Growth funds investing in similar companies to Nanomi
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nanomi
4.2 - Public trading comparable groups for Nanomi
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →